Since we had established that PRMT5-mediated H4R3me2s mark is sufficient to regulate TCF3 splicing which subsequently regulates tumor cell invasion, we asked if targeting dCAS9-PRMT5 to the TCF3 splicing locus will be sufficient to enhance invasion by altering TCF3 splicing event. The gene discussed is PRMT5; the disease is neoplasm.